Skip to content

POINTER trial: postponed or immediate drainage of infected necrotizing pancreatitis

POINTER trial: postponed or immediate drainage of infected necrotizing pancreatitis - POINTER trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON47739
Enrollment
104
Registered
2015-06-19
Start date
2015-08-04
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Geïnfecteerde necrotiserende pancreatitis Acute necrotizing pancreatitis severe acute pancreatitis

Interventions

Immediate catheter drainage after diagnosing infected necrosis while starting antibiotic treatment. If necessary necrosectomy will be performed and postponed, if feasible, until the stage of walled-
catheter drainage will be postponed under antibiotic treatment. If necessary necrosectomy will be performed and postponed, if feasible, until the stage of walled-off necrosis.

Sponsors

Academisch Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Documented infected necrotizing pancreatitis - Suspected infected necrotizing pancreatitis (if > 14 days after onset of acute pancreatitis) - Catheter drainage of the collection with infected necrosis is technically feasible - Age >= 18 years

Exclusion criteria

Exclusion criteria: - > 35 days after onset of acute pancreatitis - Indication for emergency laparotomy for abdominal catastrophe (e.g. bleeding, bowel perforation, abdominal compartment syndrome) - Previous retroperitoneal intervention for necrotizing pancreatitis - Documented chronic pancreatitis

Design outcomes

Primary

MeasureTime frame
The primary outcome consists of the Comprehensive Complication Index (CCI), including all complications between randomization and 6 months after.

Secondary

MeasureTime frame
Secondary outcome are: mortality, new onset (multi) organ failure, bleeding requiring intervention, perforation requiring intervention, fistula, incisional hernia, wound infections, endocrine and exocrine pancreas insufficiency, number of patients with severe complications (Clavien-Dindo III or higher), number of patients per Clavien-Dindo classification, number of (re-)interventions, hospital and ICU length of stay, QALYs, (in)direct costs, and budget impact.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)